Acquisition of LiqMeds Group

We are thrilled to share some exciting news that marks a significant milestone for Zydus UK. We are delighted to announce the successful acquisition of UK-based LiqMeds Group by Zydus Lifesciences through Zydus Pharmaceuticals UK Ltd.

Excited about

the opportunities

This acquisition is particularly significant as it marks the entry of Zydus into the UK market. While Zydus Lifesciences is a well-established name globally, our presence in the UK is a new and promising development.

This move underscores our commitment to enhancing healthcare solutions and accessibility for patients in the UK and beyond. LiqMeds, with its pioneering technologies and expertise, perfectly aligns with our mission to transform healthcare, and this collaboration will undoubtedly strengthen our position in the pharmaceutical industry

We are excited about the opportunities this venture will bring to both organizations, as we combine our resources, knowledge, and innovation to deliver even more comprehensive and patient-centric healthcare solutions.